In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.)
In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.)
In re Loestrin 24 Fe Antitrust Litig., No. 13-2472 (D.R.I.), Faruqi & Faruqi representing a pharmaceutical wholesaler and a proposed class of direct purchasers of Warner Chilcott’s oral contraceptive drug, Loestrin 24 Fe, alleging that Warner Chilcott and would-be generic competitors entered into a “pay for delay” conspiracy, to prevent purchasers from benefitting from lower-priced generic competition) (Faruqi & Faruqi is co-lead counsel). (settled for $120 million)
Details
Counsel
Neill W. Clark
nclark@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Joseph T. Lukens
jlukens@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Peter Kohn
pkohn@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Office
Pennsylvania
1617 JFK Boulevard, Suite 1550
Philadelphia Pennsylvania 19103
Phone (215) 277-5770
Fax (215) 277-5771